Route of Administration Determines Induction of T-Cell-Independent Humoral Responses to Adeno-Associated Virus Vectors
Open Access
- 1 April 2000
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 1 (4), 323-329
- https://doi.org/10.1006/mthe.2000.0045
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarizationNature Medicine, 1999
- Immune responses to adenovirus and adeno-associated virus in humansGene Therapy, 1999
- Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorNature Medicine, 1999
- Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse LiverBlood, 1998
- Transient Immunosuppression Allows Transgene Expression Following Readministration of Adeno-Associated Viral VectorsHuman Gene Therapy, 1998
- Gene therapy - promises, problems and prospectsNature, 1997
- Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectorsProceedings of the National Academy of Sciences of the United States of America, 1997
- Clonal selection and learning in the antibody systemNature, 1996
- Recombinant IL–12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lungNature Medicine, 1995
- Adeno-Associated Viruses: An UpdateAdvances in Virus Research, 1987